Tetra Radar · FDA Approvals · Decision date

CryoPort Inc.: FDA decision date

CryoPort Inc. (CYRX) · Q4 2026

Cryoport also anticipates two possible additional new therapy approvals (both of which have received Prescription Drug User Fee Act (PDUFA) dates from the FDA for Q4 2026), and one possible additional supplemental approval for geographic expansion from our customer base this year.

Source: 8-K of 5 November 2026

The decision is pending.

CryoPort Inc. on Tetra Radar

A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.